11 ms·
This “first” is one in a family of firsts. There have been other in vivo genetic treatments for RP (and perhaps other eye related genetic conditions) This one
by colechristensen 5y ago
This “first” is one in a family of firsts. There have been other in vivo genetic treatments for RP (and perhaps other eye related genetic conditions)
This one involves inserting a nonhuman gene into existing cells to turn them into a kind of hacked photoreceptor.
Another method involves crispr editing in place fixing the mutation to its non diseased human equivalent (apparently not possible in the article related type of RP which causes cell death, can’t fix what isn’t there)
A third kind involves generating a stem cell line of the patient, using crispr to fix the faulty gene, growing, and then implanting fixed retinal cells into the patient.
I believe all three have now had “firsts” in human trials.
The article in question seems interesting, but the less exciting of the three.
- dang 5y agoWe've de-firsted the title above. Actually that's pretty much always a good move in titles. If something is interesting, it's probably interesting even if it isn't the first, and most claims to firstiness tend to have distracting effects on threads.